Matthew Loughran
Recent Medicare Advantage and Part D rule increases regulatory oversight on third party marketers
Health Industry Washington Watch ·
Supreme Court overturn of Roe v. Wade could impact drug and device makers
Health Industry Washington Watch ·
SCOTUS Review of Rule 9(b) in False Claims Act cases may be on the way
Health Industry Washington Watch ·
FDA finalizes guidance on voluntary recalls, issues recommendations for industry
Life Sciences Legal Update ·
OSHA reopens comments on COVID-19 Healthcare Emergency Temporary Standard
Health Industry Washington Watch ·